CSF Penetrative Antibiotics for Bacterial Meningitis
Third-generation cephalosporins (ceftriaxone 2g IV every 12 hours or cefotaxime 2g IV every 6 hours) are the first-line antibiotics for bacterial meningitis because they reliably penetrate inflamed meninges and achieve bactericidal CSF concentrations against the most common pathogens. 1
Primary CSF-Penetrative Antibiotics
Excellent CSF Penetration
- Ceftriaxone: 2g IV every 12 hours (adults <60 years) 1
- Cefotaxime: 2g IV every 6 hours 1
- Chloramphenicol: 25 mg/kg IV every 6 hours (alternative for β-lactam allergy) 1
These agents achieve therapeutic CSF concentrations of 2-30 μg/mL depending on timing and degree of meningeal inflammation 2. For optimal bactericidal activity, CSF drug concentrations should reach ≥30 times the minimal bactericidal concentration (MBC) 3.
Good CSF Penetration
- Penicillin G: 2.4g (4 million units) IV every 4 hours - achieves ~8% CSF penetration 4
- Ampicillin/Amoxicillin: 2g IV every 4 hours - achieves ~16% CSF penetration 4
- Must be added for patients ≥60 years old to cover Listeria monocytogenes 1
- Meropenem: 2g IV every 8 hours - for suspected ESBL organisms 1
Adjunctive Agents for Resistant Organisms
- Vancomycin: 15-20 mg/kg IV every 12 hours (target trough 15-20 μg/mL) 1
- Add when penicillin-resistant pneumococci suspected (recent travel to high-resistance areas)
- Penetrates reliably into inflamed CSF in children; less predictable in adults 5
- Rifampicin: 600 mg IV/PO every 12 hours 1
- Alternative to vancomycin for resistant pneumococci
- Achieves ~25% CSF penetration 4
Moderate CSF Penetration
- Co-trimoxazole: 10-20 mg/kg (trimethoprim component) in 4 divided doses 1
- For Listeria in penicillin-allergic patients
- Add for immunocompromised patients ≥60 years 1
Critical Dosing Principles
High-dose therapy is essential - standard doses are insufficient for meningitis. The blood-brain barrier requires:
- Doses 2-4 times higher than for systemic infections 6
- Frequent dosing intervals to maintain CSF concentrations above MBC 3
- CSF concentrations must exceed 10-30 times the MBC for maximal bactericidal activity 3
Age-Specific Modifications
Adults <60 years:
- Ceftriaxone or cefotaxime alone (empiric) 1
Adults ≥60 years:
- Ceftriaxone/cefotaxime PLUS ampicillin 2g every 4 hours 1
- This covers Listeria monocytogenes, which has increasing incidence in elderly
Immunocompromised (including diabetics, alcohol misuse):
- Same as ≥60 years: add ampicillin 1
Resistance Considerations
If recent travel (<6 months) to areas with penicillin-resistant pneumococci:
- Add vancomycin 15-20 mg/kg every 12 hours OR rifampicin 600mg every 12 hours 1
- Continue ceftriaxone/cefotaxime as backbone therapy
For confirmed resistant pneumococci:
- Ceftriaxone/cefotaxime PLUS vancomycin PLUS rifampicin 1
- Treat for 14 days (vs. 10 days for sensitive strains) 1
Common Pitfalls
Underdosing: Standard systemic infection doses are inadequate for meningitis - always use meningitis-specific high doses 6
Forgetting ampicillin in elderly: Listeria coverage is critical in patients ≥60 years and immunocompromised 1
Vancomycin monotherapy: Never use vancomycin alone - it has unpredictable CSF penetration and must be combined with ceftriaxone/cefotaxime 5
Delaying antibiotics for imaging: Start antibiotics immediately after blood cultures if CT needed before LP 1
Pathogen-Specific Definitive Therapy
Once organism identified:
- Meningococcus: Continue ceftriaxone/cefotaxime for 5 days (if recovered) 1
- Pneumococcus (sensitive): Continue ceftriaxone/cefotaxome or switch to penicillin G for 10 days 1
- Pneumococcus (resistant): Ceftriaxone + vancomycin + rifampicin for 14 days 1
- Listeria: Ampicillin 2g every 4 hours for 21 days 1
- H. influenzae: Continue ceftriaxone/cefotaxime for 10 days 1
The evidence strongly supports that antibiotic choice based on CSF penetration characteristics directly impacts mortality and neurological outcomes in bacterial meningitis 1.